1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 51-60 of 331 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionPagani, I.S.; Dang, P.; Saunders, V.A.; Grose, R.; Shanmuganathan, N.; Kok, C.H.; Carne, L.; Rwodzi, Z.; Watts, S.; McLean, J.; Braley, J.; Altamura, H.; Yeung, D.T.; Branford, S.; Yong, A.S.M.; White, D.L.; Hughes, T.P.; Ross, D.M.
20179.4 T MR microscopy of the substantia nigra with pathological validation in controls and diseaseMassey, L.A.; Miranda, M.A.; Al-Helli, O.; Parkes, H.G.; Thornton, J.S.; So, P.W.; White, M.J.; Mancini, L.; Strand, C.; Holton, J.; Lees, A.J.; Revesz, T.; Yousry, T.A.
2021The future burden of head and neck cancers attributable to modifiable behaviors in Australia: a pooled cohort studyLaaksonen, M.A.; Canfell, K.; MacInnis, R.J.; Banks, E.; Byles, J.E.; Giles, G.G.; Magliano, D.J.; Shaw, J.E.; Hirani, V.; Gill, T.K.; Mitchell, P.; Cumming, R.G.; Salagame, U.; Vajdic, C.M.
2018Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits SchemeHajati, F.; Atlantis, E.; Bell, K.; Girosi, F.
2021Pre- And postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCDSchmoll, H.J.; Stein, A.; van Cutsem, E.; Price, T.; Hofheinz, R.D.; Nordlinger, B.; Daisne, J.F.; Janssens, J.; Brenner, B.; Reinel, H.; Hollerbach, S.; Caca, K.; Fauth, F.; Hannig, C.V.; Zalcberg, J.; Tebbutt, N.; Mauer, M.E.; Marreaud, S.; Lutz, M.P.; Haustermans, K.
2011Methodological issues associated with collecting sensitive information over the telephone - experience from an Australian non-suicidal self-injury (NSSI) prevalence studyTaylor, A.; Martin, G.; DalGrande, E.; Swannell, S.; Fullerton, S.; Hazell, P.; Harrison, J.
2014The impact of low muscle mass definition on the prevalence of sarcopenia in older AustraliansYu, S.; Appleton, S.; Adams, R.; Chapman, I.; Wittert, G.; Visvanathan, T.; Visvanathan, R.
2013A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasCortes, J.E.; Kim, D.W.; Pinilla-Ibarz, J.; Le Coutre, P.; Paquette, R.; Chuah, C.; Nicolini, F.E.; Apperley, J.F.; Khoury, H.J.; Talpaz, M.; DiPersio, J.; DeAngelo, D.J.; Abruzzese, E.; Rea, D.; Baccarani, M.; Müller, M.C.; Gambacorti-Passerini, C.; Wong, S.; Lustgarten, S.; Rivera, V.M.; et al.
2014Preliminary development and validation of a new endof-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of lifeMcCaffrey, N.; Skuza, P.; Breaden, K.; Eckermann, S.; Hardy, J.; Oaten, S.; Briffa, M.; Currow, D.; Macleod, U.
2018Racial differences in long-term outcomes among older survivors of in-hospital cardiac arrestChen, L.M.; Nallamothu, B.K.; Spertus, J.A.; Tang, Y.; Chan, P.S.

Discover